Submitted by Anonymous (not verified) on 14 July 2025 - 15:50
Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Date of authorisation: 19/06/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepezza, teprotumumab, Date of authorisation: 19/06/2025, Status: Authorised